FIELD: medicine, urology. SUBSTANCE: patients affected with chronic prostatitis are treated by administering under capsule of both lobes of prostate gland suspension of viable Leipig cells taken from embryonal-origin mammals and newborn infants in dose of at least 2 min cells per 1 ml. EFFECT: effective cure for people suffering from chronic prostatitis.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DIAGNOSIS OF CHRONIC PROSTATITIS | 1998 |
|
RU2140648C1 |
| METHOD FOR DIAGNOSIS OF PROSTATE DISEASE FORMS | 0 |
|
SU1633361A1 |
| METHOD FOR TREATING THE CASES OF CHRONIC PROSTATITIS OF VARIOUS ETIOLOGY | 1999 |
|
RU2176534C2 |
| METHOD OF DIAGNOSIS OF CHRONIC PROSTATITIS | 1999 |
|
RU2140636C1 |
| METHOD FOR TREATING CHRONIC PROSTATITIS | 1995 |
|
RU2116808C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR CHRONIC PROSTATITIS | 2010 |
|
RU2450270C1 |
| METHOD OF CHRONIC PROSTATITIS TREATMENT | 1997 |
|
RU2143249C1 |
| METHOD FOR DETERMINING THE THERAPEUTIC APPROACH TO CHRONIC RECURRENT BACTERIAL PROSTATITIS | 2020 |
|
RU2723997C1 |
| METHOD TO TREAT CHRONIC PROSTATITIS AND DEVICE FOR ITS IMPLEMENTATION | 1993 |
|
RU2103025C1 |
| METHOD FOR ASSESSING THE ACTIVITY OF AN INFLAMMATORY PROCESS IN CHRONIC ABACTERIAL PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME | 2019 |
|
RU2713911C1 |
